We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MITPF market cap is 451.63M. The company's latest EPS is EUR -2.5931 and P/E is -0.08.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 96.52M | 9.03M | 22.67M | 67M | 40.16M |
| Operating Income | 26.98M | -83.68M | -87.88M | -26.25M | -126.92M |
| Net Income | -26.57M | -92.09M | -116.88M | -59.62M | -173.5M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 397.64M | 521.99M | 421.92M | 442.41M | 286.55M |
| Total Liabilities | 234.35M | 364.25M | 388.08M | 408.73M | 389.8M |
| Total Equity | 163.3M | 157.74M | 33.84M | 33.69M | -103.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -46.83M | -80.03M | -74.39M | -56.82M | -2.18M |
| Investing | -20.46M | -16.21M | -54.68M | -25.49M | 3.45M |
| Financing | -1.95M | 185.19M | 23.25M | 77.87M | -20.54M |
| Market Cap | 451.63M |
| Price to Earnings Ratio | -0.08 |
| Price to Sales Ratio | 0.37 |
| Price to Cash Ratio | 1.64 |
| Price to Book Ratio | -0.14 |
| Dividend Yield | - |
| Shares Outstanding | 66.91M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 3.25k (100%) |
| Company Name | Mithra Pharmaceuticals SA (PK) |
| Address |
rue saint-georges 5 liege, liege 4000 |
| Website | https://www.mithra.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
